NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Us2.ai

Us2.ai

Private
SingaporeHealthcare & Life Scienceshttps://us2.ai/

Last Round

Series A

Apr 14, 2022

Total Funding Raised

$19.18M

Company Overview

Us2.ai is a healthtech company that provides an AI-powered platform to automate the analysis and reporting of echocardiograms for cardiovascular research and clinical diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Healthcare Analytics, Medical Devices

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

echocardiography analysismedical AIautomated reportingcardiovascular ultrasoundclinical decision supportAI echomedical imaging softwareusage-based SaaSDICOM analysisPACS integrationcardiology workflowAI diagnosticsdigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Us2.ai Comparables

Compare Us2.ai with similar companies based on industry and business-model similarity.

Us2.ai comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ultromics
91%
Ligence
88%
iCardio.ai
84%

Us2.ai Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 14, 2022
SeedJan 7, 2020
GrantNov 13, 2019

Key People

Founding team and executive leadership

James Hare

Co-founder And CEO

Founding Team

Us2.ai Investors

Notable investors and investment history

Us2.ai investors
InvestorRounds
PartechSeries A, Seed
Startup SGGrant
A. M. Pappas & AssociatesSeries A
Peak XV PartnersSeries A, Seed
EDBISeries A, Seed
HEAL PartnersSeries A
StartUp HealthSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 12, 2025

    Presented study on cardiac amyloidosis diagnosis at ESC Congress 2025.

  • Jul 23, 2025

    Presented study on automated cardiac amyloidosis detection at ASE 2025.

Us2.ai Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Us2.ai Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Us2.ai's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore
Employee Range32
Year Founded2017
Last FundingApr 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.